Related Experiment Videos
HPV DNA detection and typing in cervical scrapes
Peter J F Snijders1, Adriaan J C van den Brule, Marcel V Jacobs
1Section Molecular Pathology, Department of Pathology, VU University Medical Center, The Netherlands.
Methods in Molecular Medicine
|December 15, 2005
Summary
The GP5+/6+ polymerase chain reaction (PCR) assay detects human papillomavirus (HPV) DNA in cervical samples. This method efficiently identifies and types high-risk HPV genotypes using enzyme immunoassay and reverse line blot.
Area of Science:
- Molecular biology
- Virology
- Clinical diagnostics
Background:
- Polymerase chain reaction (PCR) assays with consensus primers are widely used for detecting multiple human papillomavirus (HPV) types simultaneously in clinical specimens.
- Accurate and efficient HPV detection is crucial for cervical cancer screening and management.
Purpose of the Study:
- To provide a detailed description of the GP5+/6+ PCR method for HPV DNA detection and typing.
- To evaluate the assay's utility in crude cervical scrape and biopsy specimens.
Main Methods:
- The GP5+/6+ PCR assay utilizes consensus primers for broad-spectrum HPV DNA amplification.
- Detection of amplified DNA involves an enzyme immunoassay (EIA) using digoxigenin-labeled probes.
- Genotyping of positive samples is performed using a reverse line blot procedure with specific oligonucleotide probes.
Main Results:
- The GP5+/6+ PCR method allows for the detection of HPV DNA in crude cervical extracts.
- The enzyme immunoassay (EIA) effectively identifies the presence of high-risk HPV genotypes.
- Reverse line blot genotyping enables the typing of up to 37 different HPV (sub)types in a single assay.
Conclusions:
- The GP5+/6+ PCR assay is a robust and versatile method for detecting and typing HPV DNA in clinical samples.
- This assay facilitates efficient identification of high-risk HPV genotypes, aiding in clinical diagnostics and research.